$28.36−2.72 (−8.74%)
At close: Oct 26, 2026, 4:00 PM ET· NYSE · USD
Embotelladora Andina (AKO-B) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue is 100% below its peak, net margin 4.8%. Worth your attention in FY22: Returns vs FCF (130%). Visible in the receipts below.
The four lines that matter · FY18–FY22
Revenue ($M)▲19.3%
3,115.8
FY18→FY22CAGR −96.0%/yr
Net income ($M)▼18.6%
150.6
one-off year: see footnoteCAGR −96.1%/yr
Free cash flow ($M)▲26.2%
247.2
FY18→FY22CAGR −95.8%/yr
Diluted EPS—
0.00
no value for 1 of 5 yearsCAGR —
What the receipts whisper · what a headline number hides
Share count
+0.0%
946.6mn → 946.6mn diluted shares since FY18. Broadly flat, so EPS moves with net income rather than with the share count.
Capex
$219.0M
+33.8% YoY in FY22 · 7.0% of revenue.
Returns vs FCF
130%
$321.7M returned vs $247.2M of FCF in FY22. The gap comes off the balance sheet (see net cash).
What the income statement says · FY18–FY22
Where every revenue dollar goes · FY22 ($M)
5¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 42.1% → 38.7%. Net margin 4.8% is below the sector median.
The receipt · income statement · FY18–FY22 USD billions except per-share & ratios · hover a line for its definition
USD billions except per-share & ratios
| Line item | FY22 | FY21 | FY20 | FY19 | FY18 | YoY | CAGR 18→22 |
|---|---|---|---|---|---|---|---|
| Revenue & profitability | |||||||
Revenue | 3.1 | 2.6 | 2.4 | 1,324,697.7 | 1,163,830.8 | ▲19.3% | −96.0% |
Cost of revenue | 1.9 | 1.6 | 1.4 | 780,617.7 | 673,447.2 | ▲17.9% | −95.9% |
Gross profit | 1.2 | 1.0 | 0.9 | 544,079.9 | 490,383.6 | ▲21.7% | −96.0% |
Selling, general & admin | 0.5 | 0.4 | 0.4 | 242,674.5 | 218,267.8 | ▲22.5% | −96.1% |
Total operating expenses | 0.8 | 0.7 | 0.6 | 386,519.5 | 344,767.3 | ▲20.7% | −96.1% |
Operating incomefeeds ROC rank | 0.4 | 0.3 | 0.3 | 157,560.4 | 145,616.2 | ▲23.6% | −95.9% |
Other income, net | −0.1 | −0.1 | −0.1 | 18,477.5 | −39,164.8 | — | — |
Pretax income | 0.3 | 0.2 | 0.2 | 176,037.9 | 106,451.4 | ▲14.0% | −96.0% |
Income tax | 0.1 | 0.1 | 0.1 | 45,546.1 | 38,655.9 | ▲124.9% | −95.8% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 0.2 | 0.2 | 0.2 | 130,491.8 | 67,795.5 | ▼18.6% | −96.1% |
| Per share | |||||||
Diluted EPSbuyback-sensitive | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Diluted shares (mn) | 946.57 | 946.57 | 946.57 | 946.57 | 946.57 | ▲0.0% | +0.0% |
| Margins | |||||||
Gross margin61st pct in Consumer Defensive | 38.7% | 38.0% | 39.8% | 41.1% | 42.1% | ▲0.7pp | −3.4pp |
Operating margin | 13.0% | 12.5% | 13.1% | 11.9% | 12.5% | ▲0.5pp | +0.4pp |
Net margin50th pct in Consumer Defensive | 4.8% | 7.1% | 7.2% | 9.9% | 5.8% | ▼2.2pp | −1.0pp |
FY21 effective tax rate was 23% vs a 31% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was 45% vs a 31% norm for this window, likely a one-time item; see the filing.
3 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2023-04-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Embotelladora Andina's revenue last fiscal year?
Embotelladora Andina reported revenue of $3,115.8M in fiscal 2022, up 19.3% from fiscal 2021.
What was Embotelladora Andina's net income?
Embotelladora Andina reported net income of $150.6M in fiscal 2022, a net margin of 4.8%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.